1) Naokang
脑康
1.
Protective Effect of Naokang on Hemorrhagic Cerebral Apoplexy of Rats;
脑康对大鼠出血性脑卒中的保护作用
2.
Objective To observe the inhibition effects of Naokang on platelet agglutination.
目的 :观察脑康对血小板聚集的抑制作用。
2) Naoxuekang
脑血康
1.
The Inflammatory Reaction and the Effect of Naoxuekang Intervention to the Patients with Acute Cerebral Infarction;
急性脑梗死炎性反应及其脑血康干预研究
2.
Influence of Naoxuekang on expression of proteaseactivated receptor1 in rats with intracerebral hemorrhage;
脑血康对脑出血蛋白酶激活受体-1表达的影响
3) Naokang granulation
脑康颗粒
1.
To study the palletizing method of Naokang granulation,taking the contents of puerarin and palletizing procedure as the evaluation indexes,the preparation of Naokang granulation was optimized with joint fluidized granulation of spray drying and one-step palletizing.
为了建立脑康颗粒的制粒方法 ,以葛根素含量和制粒情况作为评价指标 ,采用喷雾干燥———一步制粒联合流化制粒技术对制粒条件进行优化。
4) piracetam
脑复康
1.
Clinical Study on Levoamlodipine Besylate Combined with Piracetam in the Treatment of Vascular Dementia;
苯磺酸左旋氨氯地平联用脑复康治疗血管性痴呆的临床研究
2.
The comparison of clinical efficacy of Donepezil and piracetam on treatment of vascular cognitive impairment;
安理申与脑复康治疗血管性认知功能障碍的疗效比较
5) Xinnaokang
心脑康
1.
Determination of salvianolic acid B in Xinnaokang capsule;
HPLC法测定心脑康胶囊中丹酚酸B的含量
6) Naobingkang
脑病康
1.
The Present of Rage in Diabetes Complicating With Stroke in Rat Treatment With Naobingkang Decoction;
脑病康对糖尿病性脑梗死大鼠脑组织RAGE的表达研究
补充资料:脑康
分子式:C19H26N6O6
分子量:暂无
CAS号:437-74-1
性质:暂无
制备方法:暂无
用途:适用于脑血栓形式等缺血性脑血管疾病及中风后遗症。
分子量:暂无
CAS号:437-74-1
性质:暂无
制备方法:暂无
用途:适用于脑血栓形式等缺血性脑血管疾病及中风后遗症。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条